HEALTH

FDA approves nonprescription Zyrtec-D for ages 12 and up

BY Michael Johnsen

ROCKVILLE, Md. The Food and Drug Administration on Friday approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg) for nonprescription use in adults and children 12 years of age and older.

“The approval of this widely-used drug for nonprescription use will enable many people to have access to another effective treatment for their allergy symptoms,” stated Andrea Leonard-Segal, director, Division of Nonprescription Clinical Evaluation in the FDA’s Center for Drug Evaluation and Research. “This approval reflects FDA’s commitment to bringing prescription drugs to the over-the-counter market when they can be safely used without a prescription.

Zyrtec-D’s common side effects include drowsiness, fatigue, and dry mouth. Sales of the drug are subject to restrictions in the Combat Methamphetamine Epidemic Act.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Judge dismisses important J&J claim in Red Cross case

BY Michael Johnsen

WASHINGTON A federal judge on Monday dismissed an important part of the lawsuit brought by Johnson & Johnson against the American Red Cross seeking to restrict the Red Cross’s use of its emblem on first aid, health, safety and emergency preparedness products, the Red Cross announced Tuesday.

The judge’s ruling dismissed entirely the J&J claim that the Red Cross promised not to engage in the sale of first aid, health, safety and emergency preparedness products.

“I appreciate the court’s decision and hope that Johnson & Johnson will reassess their actions and drop the case altogether,” stated Mark Everson, president and chief executive officer of the American Red Cross. “As the recent wildfires in California demonstrated, the Red Cross has an important mission to perform, and we want to put this distraction behind us and do the work the American people expect us to do.”

Following a hearing on Monday, Oct. 29, at the United States District Court for the Southern District of New York, Judge Jed Rakoff ruled that the “promissory estoppel” claim, a very significant portion of the pharmaceutical company’s lawsuit against the Red Cross, was “dismissed with prejudice.” The judge’s ruling also means that J&J cannot refile arguments on this claim.

The judge’s order comes nearly three months after J&J filed suit against the Red Cross for the Red Cross’ use of its emblem on products it sells to the public.

The court has set a schedule for hearing the remaining claims early next year.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Lil’ Drug Store signs exclusivity deal with Carmex

BY Michael Johnsen

CEDAR RAPIDS, Iowa Lil’ Drug Store has been chosen to be the exclusive distributor of Carmex Lip Balm to the convenience class of trade, the company announced Wednesday.

“With over 140,000 convenience stores nationwide, this is a major opportunity for both Lil’ Drug and Carma,” stated Mike Pietsch, vice president of sales and marketing for Carma Laboratories, which distributes Carmex.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?